News and Announcements
OncoSil Medical Presents at Asia BiotechInvest
- Published May 06, 2016 2:27PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
4th May 2016, ASX Announcement
OncoDil Medical Limied (ASX: OSL) (OncoSil Medical or the Company) a late stage medical devices company focused on localised treatments for patients with pancreatic cancer and liver cancer, today announced that Chief Executive Officer, Daniel Kenny will present at the Asia Biotech Invest conference at the Hong Kong Convention Centre, Hong Kong on Thursday 5 May 2016.
The Asia Biotech Invest conference is hosted by AusBiotech as part of their Global Investment Event Series and runs from 5 to 6 May 2016 bringing together a number of institutional investors, partners and life sciences companies from across the Asia Pacific region. Mr Kenny and Chief Financial Officer, Tom Milicevic will also participate in one-on-one meetings with Asian investors during and prior to the conference.
To view the presentation, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
